BeOne Medicines (ONC) FCF Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1,525.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -341.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 43,511.00 |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 1,187.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,187.00 |
| Dec 31, 2025 | -1,699.00 |
| Sep 30, 2025 | 2,346.00 |
| Jun 30, 2025 | 4,232.00 |
| Mar 31, 2025 | 4,354.00 |
| Dec 31, 2024 | 14,246.00 |
| Sep 30, 2024 | -238.00 |
| Jun 30, 2024 | 5,800.00 |
| Mar 31, 2024 | 9,523.00 |
| Dec 31, 2023 | 910.00 |
| Sep 30, 2023 | 18,084.00 |
| Jun 30, 2023 | 4,584.00 |
| Mar 31, 2023 | -4,833.00 |
| Dec 31, 2022 | -21,932.00 |
| Sep 30, 2022 | 9,961.00 |
| Jun 30, 2022 | 18,758.00 |
| Mar 31, 2022 | -10,741.00 |
| Dec 31, 2021 | 52,218.00 |
| Sep 30, 2021 | 10,971.00 |
| Jun 30, 2021 | 9,839.00 |
| Mar 31, 2021 | 71,375.00 |
| Dec 31, 2020 | 15,722.00 |
| Sep 30, 2020 | 13,292.00 |
| Jun 30, 2020 | -37,180.00 |
| Mar 31, 2020 | -44,920.00 |
| Dec 31, 2019 | -28,772.00 |
| Sep 30, 2019 | -19,936.00 |
| Jun 30, 2019 | 17,850.00 |
| Mar 31, 2019 | 10,190.00 |
| Dec 31, 2018 | -94,264.00 |
| Sep 30, 2018 | -31,044.00 |
| Jun 30, 2016 | -583,163.00 |
| Mar 31, 2016 | -291,513.00 |